Skip to main navigation Skip to search Skip to main content

Abstract

Several lines of evidence suggest that ovarian steroids modulate immune function in women. Women are at higher risk of autoimmune disease than men; generate more robust humoral responses to vaccination than men; and plas-ma cytokine levels and the immune response to certain vaccines change throughout the menstrual cycle. Aging is accom-panied by a decline in immunity referred to as "immune senescence" that significantly contributes to increased morbidity and mortality in the elderly. Aging is also associated with menopause, one of the most dramatic age-related physiological changes in women. Given the strong evidence for sex differences in immune function between pre-menopausal adult women and men, it has been suggested that the loss of ovarian steroids associated with menopause might contribute to de-creased immune function in post-menopausal women. However, we do not yet fully understand the interplay between ovarian and immune senescence. In this article, we review studies that have investigated the impact of menopause and hormone therapy on changes in immune function.

Original languageEnglish
Pages (from-to)101-111
Number of pages11
JournalOpen Longevity Science
Volume6
DOIs
StatePublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • B cells
  • Cytokines
  • Estrogen
  • Immune senescence
  • Menopause
  • Progesterone
  • T cells

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Fingerprint

Dive into the research topics of 'The impact of menopause on immune senescence'. Together they form a unique fingerprint.

Cite this